Monoclonal antibodies (mAbs) have emerged as a groundbreaking innovation in the field of medical science, transforming the way we treat various diseases and conditions. These highly specialized antibodies, designed to target specific cells or proteins, have paved the way for more precise and effective therapeutic interventions. From cancer to autoimmune disorders, monoclonal antibodies have revolutionized the landscape of medicine and offered hope to millions of patients worldwide.
